Quick Answer
Verrica Pharmaceuticals Inc. reported Operating Income of -$12.19 million for fiscal year 2025.
Verrica Pharmaceuticals Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$12.19M | +81.5% |
| 2024 | -$65.92M | -0.2% |
| 2023 | -$65.76M | -208.8% |
| 2022 | -$21.30M | +31.1% |
| 2021 | -$30.91M | +23.1% |
| 2020 | -$40.18M | -33.6% |
| 2019 | -$30.08M | -37.5% |
| 2018 | -$21.88M | -390.9% |
| 2017 | -$4.46M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.63M | +107.9% | +7.7% |
| June 30, 2025 | $1.51M | +109.9% | +118.6% |
| March 31, 2025 | -$8.13M | +56.3% | +60.7% |
| September 30, 2024 | -$20.70M | +13.4% | -36.2% |
| June 30, 2024 | -$15.21M | -30.9% | +18.2% |
| March 31, 2024 | -$18.60M | -162.4% | +22.2% |
| September 30, 2023 | -$23.92M | -1751.7% | -105.9% |
| June 30, 2023 | -$11.62M | -27.4% | -63.9% |
- Verrica Pharmaceuticals Inc. showed an increase of +81.5% in Operating Income compared to the prior fiscal year.
- Over the 2017–2025 period, Verrica Pharmaceuticals Inc.’s operating income has declined by 173.4% (from -$4.46 million to -$12.19 million).
- The most recent figure is from Verrica Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: